Assay And Drug Development Technologies SCIESCI

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies coverage includes:

-Assay design, target development, and high-throughput technologies-

Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-

Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-

Approaches to assays configured for gene families, inherited, and infectious diseases-

Assays and strategies for adapting model organisms to drug discovery-

The use of stem cells as models of disease-

Translation of phenotypic outputs to target identification-

Exploration and mechanistic studies of the technical basis for assay and screening artifacts

ASSAY and Drug Development Technologies 提供了对新技术和强大工具的访问，这些技术和强大的工具可在早期筛查中取得重大进展。发表在该杂志上的这项研究为药物发现和开发带来了重要的治疗方法和平台。这本享有盛誉的同行评审期刊收录了以应用为导向的技术评论、新颖和新兴研究领域的热点问题以及方法论和技术应用方面的报告。

ASSAY 和药物开发技术的覆盖范围包括：

-检测设计、目标开发和高通量技术-

通过临床前候选者选择来优化和药物化学-

实验室自动化、样本管理、生物信息学、数据挖掘、虚拟筛选和数据分析-

为基因家族、遗传病和传染病配置的检测方法-

使模式生物适应药物发现的试验和策略-

使用干细胞作为疾病模型-

将表型输出转化为目标识别-

化验和筛选伪影技术基础的探索与机理研究

该刊已被国际权威数据库SCIE、SCI收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映生化研究方法-医学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2022年影响因子为1.8，平均审稿速度为>12周，或约稿，近三年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。